TLC590 Clinical Trials (2026): 5 Studies for Postsurgical Pain Management & Hallux Valgus
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
5 TLC590 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 4 indications (including Postsurgical Pain Management & Hallux Valgus) and 1,050 total planned enrollment. 1 Phase 3 TLC590 trial and 2 Phase 2 are listed. 2 TLC590 clinical trials are actively recruiting at 4 U.S. sites across 1 state. Most recent activity: NCT06574269 (Aug 2026).
Where to Participate: All TLC590 Trial Sites in the U.S. (4 sites across 1 state)
Every actively recruiting TLC590trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| TX | First Surgical Hospital | Bellaire77401 | NCT06574269 | Map |
| TX | First Surgical Hospital | Bellaire77401 | NCT07222748 | Map |
| TX | Memorial Hermann Village | Houston77043 | NCT06574269 | Map |
| TX | Memorial Hermann Village | Houston77043 | NCT07222748 | Map |
TLC590 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | completed | unknown | Total |
|---|---|---|---|---|
| P1/P2 | 1 | 1 | ||
| P2 | 1 | 1 | 2 | |
| P2/P3 | 1 | 1 | ||
| P3 | 1 | 1 |
Recruiting TLC590 clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06574269 | A Study on TLC590 for Managing Postsurgical Pain | P2 | Postsurgical Pain Management | 120 | Sep 2024 |
| NCT07222748 | A Study of TLC590 for Postsurgical Pain Following Bunionectomy | P3 | Postoperative Pain | 300 | Nov 2025 |
TLC590 clinical trials by indication
Postsurgical Pain Management (2)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06574269 | — | P2 | recruiting | A Study on TLC590 for Managing Postsurgical Pain |
| NCT05161637 | — | P2/P3 | unknown | Phase 2/3 Study of TLC590 for Postsurgical Pain Management |
Postoperative Pain (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07222748 | — | P3 | recruiting | A Study of TLC590 for Postsurgical Pain Following Bunionectomy |
Hallux Valgus (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT03838133 | — | P2 | completed | A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy |
Inguinal Hernia (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT03591146 | — | P1/P2 | completed | Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management |
All TLC590 trials (5)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06574269 | A Study on TLC590 for Managing Postsurgical Pain | P2 | recruiting | 120 | TLC Biopharmaceuticals, Inc. | Sep 2024 | |
| NCT07222748 | A Study of TLC590 for Postsurgical Pain Following Bunionectomy | P3 | recruiting | 300 | TLC Biopharmaceuticals, Inc. | Nov 2025 | |
| NCT05161637 | Phase 2/3 Study of TLC590 for Postsurgical Pain Management | P2/P3 | unknown | 415 | Taiwan Liposome Company | Apr 2025 | |
| NCT03838133 | A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy | P2 | completed | 150 | Taiwan Liposome Company | Mar 2019 | |
| NCT03591146 | Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management | P1/P2 | completed | 65 | Taiwan Liposome Company | Jul 2018 |
TLC590 clinical trials: frequently asked questions
- How many TLC590 clinical trials are there?
- 5 TLC590 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants. 2 are marked completed.
- Are TLC590 clinical trials recruiting in 2026?
- Yes — 2 TLC590 trials are actively recruiting in 2026, with 4 U.S. sites across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is TLC590 being studied for?
- TLC590 is being studied for Postsurgical Pain Management, Hallux Valgus, Inguinal Hernia, Postoperative Pain. The trials are grouped by indication on this page.
- What phase is TLC590 in?
- TLC590 clinical trials span 1 Phase 3, 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors TLC590 clinical trials?
- The lead sponsor across the most TLC590 trials is Taiwan Liposome Company, with 1 additional lead sponsor listed in the data. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming TLC590as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: